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improvement in his pulmonary physiology; FEV, 1.96 1 and 
FVC 3.18 1 recorded. 
Discussion 
The first descriptions of disease currently recognized as 
sarcoidosis were documented at the end of the 19th century 
and concerned skin eruptions (1). Since that time, it has 
been realized that it is a systemic disease characterized 
histologically by non-caseating granulomata. An aetiologi- 
cal agent eludes characterization. A number of recognizable 
patterns of disease at presentation are documented includ- 
irrg Lofgren’s syndrome (2). Lymph node enlargement is 
frequently found in sarcoidosis, occurring in up to 90% of 
p&&nts during the course of their disease. The most 
cemmon pattern of mediastinal adenophy is bilateral 
involvement of the bronchopulmonary, right paratracheal 
and aortopulmonary nodes, but any combination can occur 
(3). Despite this, the incidence of obstruction of the 
intrathoracic vasculature is low. To the authors’ knowl- 
edge, only four reports of superior vena caval(4-7) and pne 
of innominate vein (8) obstruction due to sarcoid are 
described in the literature. No cases of subclavian vein 
obstruction have been reported previously. Obstruction of 
vessels can be caused by two mechanisms: involvement of 
the vessel wall with granulomata or extrinsic compression 
by enlarged lymph nodes. In the present case, the obstruc- 
tion has been demonstrated radiograhically (Plate 1) to be 
due to external compression by intrathoracic lymphaden- 
opathy; however, concurrent microscopic involvement of 
the vessel wall could not be excluded. 
The diagnosis of sarcoidosis in this case is supported by 
many factors: the initial presentation of uveitis and lym- 
phadenopathy, abnormal pulmonary physiology which 
improved with oral corticosteroids, the positive Kveim, the 
intrathoracic biopsy material obtained, and the raised 
serum ACE during the current recrudescence. The subse- 
quent course of the illness and response to therapy would 
not be typical for any other granulomatous disease. 
To the authors’ knowledge, this case is the first to present 
on two separate occasions with intraothoracic venous 
obstruction, the second with an increase in activity of 
disease. At present, the symptoms have resolved with 
anticoagulation and corticosteroid therapy. 
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Introduction tumour is most commonly breast, colon or kidney (1) 
although other sites have been reported, including sarcoma 
(2). The present case report describes a case in which 
bilateral metastases secondary to a chondroblastic osteo- 
sarcoma of the spine presented acutely with dyspnoea, and 
removal of these lesions resulted in great symptomatic 
improvement. However, the patient’s subsequent rapid 
deterioration and death highlights that the prognosis in 
such cases is poor. 
Endobronchial metastases from non-pulmonary neoplas- 
mas are rare. When they occur, the primary site of the 
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PLATE 1. Histology of the primary lesion showing tumour 
osteoid preduction adjacent to hypercellular cartilage with 
mildly pleomorphic nuclei, some of which are binucleate. 
(Haematoxylin and eosin stain, original magnification 
x 200). 
Case Report 
A 30-year-old man initially presented in late 1994 with a 
6-month history of back pain, 2 months of leg weakness 
and urinary incontinence for 4 days. Magnetic resonance 
imaging revealed an extradural tumour extending from the 
L3 to the Sl level involving the exit foramina and infiltrat- 
ing the left iliac muscles. He underwent a decompressive 
laminectomy, and multiple biopsies revealed the tumour 
to be a chondroblastic osteosarcoma (Plate 1). This 
failed to respond to chemotherapy with cisplatinum and 
adriamycin, so he was given second-line drugs using ifos- 
famide and etoposide, as well as concurrent radiotherapy. 
This resulted in an incomplete response. In August 1995, he 
represented with bladder dysfunction and foot drop. 
This developed into complete paraplegia despite further 
radiotherapy. 
Seven months later, he presented as an emergency with 
a l-week history of haemoptysis and a 2-day history 
of dyspnoea and wheeze. Examination revealed a pale, 
dyspnoeic young man with stridor, a respiratory rate 
of 30 breaths min - ‘, a medium-sized pleural effusion on 
the right lung and a large right hypochondria1 mass. 
Investigations showed haemoglobin of 6.4 g dl- ‘, and 
chest X-ray confirmed a medium-sized right-sided pleural 
effusion and also revealed two calcified masses in the left 
midzone. Peak flow was 160 1 min - ’ and blood gas analysis 
showed a pH of 7.34, PO, 5.7 and PCO, 4.8, whilst 
breathing air. 
His symptoms failed to settle completely with bron- 
chodilators, steroids, blood transfusion and aspiration 
of his effusion. Fibre-optic bronchoscopy revealed 
bilateral pedunculated endobronchial masses; one in the 
right bronchus intermedius and one in the left main 
bronchus. These filled most of the lumen and moved ‘w’ith 
respiration. 
He was referred for laser ablation of these lesions but, 
because of a sudden deterioration, he underwent an emer- 
gency rigid bronchoscopy, during which his oxygen satura- 
PLATE 2. Pieces of the endobronchial metastases from 
the left main bronchus following removal via rigid 
bronchoscopy. 
tion fell to 40%, and he needed rapid piecemeal removal of 
both lesions (Plate 2) with forceps. This resulted in good 
clearance and his oxygen saturation rose to 100%. Histol- 
ogy of the endobronchial lesions showed them to be metas- 
tases from the chondroblastic osteosarcoma. Following the 
procedure, his breathing improved greatly, his FEV, rose 
from 0.5 to 2.15 1 post procedure and he was able to be 
discharged home. 
Five weeks later, he was re-admitted with a generalized 
deterioration but no clinical or physiological evidence of 
an endobronchial recurrence. He died peacefully 4 weeks 
later. 
Discussion 
Endobronchial metastases occur in only 2% of subjects with 
pulmonary metastatic disease (3,4). Breast, colon and renal 
primary tumours are responsible for about 80% of these, 
whilst other reported primary sites include nasopharynx, 
bladder, thyroid, ovary and prostate (1). Endobronchial 
metastases arising from sarcoma have only rarely been 
reported before, and the authors are unaware of any 
previous reports where chondroblastic osteosarcoma has 
presented in this ,way. Bilateral synchronous endobronchial 
metastases have been reported occasionally in large series 
(1,5), but a literature review failed to identify any caused by 
sarcoma (2). 
The presence of endobronchial metastases has usually 
been taken to denote a poor prognosis as widespread 
extrabronchial metastases are also usually present. This 
was certainly the case here, where there was evidence of 
both pleural and abdominal spread and where, in spite 
of excellent endobronchial clearance, there was a rapid 
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deterioration to death in less than 3 months. However, with 
obvious radiological evidence of both intrapulmonary and 
pleural disease, it was important to avoid the pitfall of 
ascribing his respiratory symptoms to these, and failing to 
consider endobronchial disease. Stridor in this context 
should always prompt a search for a lesion in the main 
airway, as the advent of newer endobronchial therapies, 
such as stenting, brachytherapy or laser (6), may allow 
useful symptom palliation. 
Some reports suggest better outcomes in patients 
treated for endobronchial metastases. The report of three 
patients with endobronchial metastases from sarcoma 
showed a moderate survival, with one patient dying 
5 months after the discovery of endobronchial metas- 
tases and the other two still being alive 11 and 14 months 
after this finding. The present case is in stark contrast to 
this. The poorer outcome in this case reflects not only 
the extensive nature of this patient’s extrabronchial 
disease, but also that he had previously failed to 
respond markedly to aggressive chemotherapy and 
radiotherapy. 
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Introduction 
Non-small cell lung cancer (NSCLC) is a common cause of 
death world-wide and is less responsive to chemotherapy 
than small cell lung cancer. Dermatomyositis is a rare 
condition in Chinese and is classically associated with 
underlying malignancy, although this association has been 
recently doubted by some authors (1,2). Association of 
dermatomyositis with lung cancer is less doubtful, although 
a causal relationship has not been firmly established (3). 
Whilst it is known that cancer-associated dermatomyositis 
is often more refractory to standard treatment such as the 
administration of systemic corticosteroids, little is known of 
the response of NSCLC-associated dermatomyositis to 
chemotherapy directed at the underlying lung cancer. The 
present case report describes a case of a 5%year old man 
Received 28 June 1996 and accepted in revised form 28 January 
1997. 
Correspondence should be addressed to K. W. T. Tsang, Associate 
Professor in Respiratory and Critical Care Medicine, University 
Department of Medicine, Queen Mary Hospital, The University of 
Hong Kong, Pokfulam, Hong Kong. 
who presented with dermatomyositis and was found to 
have extensive metastatic NSCLC. Both the NSCLC and 
dermatomyositis responded well to a combination of 
mitomycin-C (M), ifosphamide (I) and cis-platinum (P). 
Case History 
A 5%year old ex-smoker presented with a 2-month history 
of an erythematous and pruritic rash affecting his face 
and limbs which was resistant to topical steroid therapy 
(Plate 1). Deterioration and ulceration of the skin was 
accompanied by development of progressively disabling 
symmetrical limb girdle weakness (including inability to 
stand from sitting position and flex the neck), swallowing 
difficulty and weight loss, although there were no respirat- 
ory symptoms. Physical examination revealed an erythema- 
tous rash affecting the described areas, symmetrical limb 
girdle weakness (415) and nasal regurgitation, but there was 
no other abnormalities. 
A chest X-ray showed a right hilar shadow which 
was revealed on thoracic computerized tomography (CT) 
(Plate 2) to be a 3 cm irregular mass situated anterior to the 
